Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
60.8M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
20.7M
-
Shares change
-
+2.65M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
+$199M
-
Put/Call ratio
-
0.2
-
Number of buys
-
76
-
Number of sells
-
-31
-
Price
-
$75.84
Significant Holders of ARGENX SE - ADR (ARGX) as of Q3 2018
120 filings reported holding ARGX - ARGENX SE - ADR as of Q3 2018.
ARGENX SE - ADR (ARGX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.7M shares
of 60.8M outstanding shares and own 34.03% of the company stock.
Largest 10 shareholders include FMR LLC (3.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.93M shares), BAKER BROS. ADVISORS LP (1.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.02M shares), Redmile Group, LLC (975K shares), FEDERATED INVESTORS INC /PA/ (961K shares), venBio Select Advisor LLC (755K shares), BB BIOTECH AG (735K shares), ORBIMED ADVISORS LLC (719K shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (657K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.